NCT00569283 2013-03-26Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantNational Cancer Institute (NCI)Phase 1 Completed18 enrolled